Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision entry for this page.
    Difference
    0.0%
    Check dated 2026-06-08T16:28:14.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site release note now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a new, minor update to the site’s release/version information.
    Difference
    0.0%
    Check dated 2026-05-18T03:53:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision/version marker was updated from v3.5.2 to v3.5.3, reflecting a software release on the site.
    Difference
    0.0%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T13:43:24.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added. Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T19:55:42.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:00:42.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.